Condition: POLYARTERITIS NODOSA, CHILDHOOD-ONSET


rs139750129 in ADA2 gene and POLYARTERITIS NODOSA, CHILDHOOD-ONSET PMID 24552284 2014 Early-onset stroke and vasculopathy associated with mutations in ADA2.

PMID 24552285 2014 Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.

PMID 28493328 2017 Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood.

PMID 27059682 2016 Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.

PMID 28983775 2017 Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.

PMID 29951947 2018 Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.

PMID 27252897 2016 ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters.

PMID 28522451 2017 ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.

PMID 26867732 2016 This case series revealed large phenotypic variability in patients with ADA2 deficiency though they were homozygous for the same R169Q mutation inCECR1 Disease modifiers, including epigenetic and environmental factors, thus seem important in determining the phenotype.

PMID 25888558 2015 Unexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiency.